Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 78, Issue 7, 2011, Pages 996-1003

  Napodano, Massimo ^a   Gasparetto, Valeria ^a   Tarantini, Giuseppe ^a   Fraccaro, Chiara ^a   Yzeiraj, Ermela ^a   Gerosa, Gino ^a   Isabella, Giambattista ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

aortic stenosis; bioprosthesis; para prosthetic leak; trans catheter aortic valve implantation

Indexed keywords

AGED; AORTA BALLOON; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BIOSAFETY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART VALVE BIOPROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARA PROSTHETIC LEAK; PNEUMONIA; PROSPECTIVE STUDY; PROSTHESIS FAILURE; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THERAPY EFFECT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOPROSTHESIS; FEASIBILITY STUDIES; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; ITALY; MALE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RETREATMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 81855224743     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23181     Document Type: Article

References (21)

1. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V,. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
2. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV,. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763. (Pubitemid 47255993)
3. Grube E, Schuler G, Bullesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R,. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second and current third generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76. (Pubitemid 46970878)
4. Piazza N, Grube E, Gerkens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcome following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve Revalving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Eurointervention 2008; 4: 242-249.
5. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein SV, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K,. Transcatheter Aortic Valve Implantation. Impact on clinical and valve-related outcomes. Circulation 2009; 119: 3009-3016.
6. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG,. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006; 114: 591-596. (Pubitemid 44202060)
7. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MWA, Schuler G, Mohr F,. Transapical minimally invasive aortic valve implantation-The initial 50 patients. Eur J Cardiothoracic Surg 2008; 33: 983-988.
8. Zegdi R, Ciobotaru V, Noghin M, Sleilaty G, Lafont A, Latremouille C, Deloche A, Fabiani JN,. Is it reasonable to treat all calcified stenotic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008; 51: 579-584.
9. Piazza N, Schultz C, de Jagere PT, Serruys P,. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure. Insights into valve-in-valve implantation ("Russian Doll concept"). Catheter Cardiovasc Interv 2009; 73: 530-539.
10. Ruiz CA, Laborde JC, Condado JF, Chiam PTL, Condado JA,. First percutaneous transcatheter aortic valve-in-valve implantation with three year follow-up. Catheter Cardiovasc Interv 2008; 72: 143-148.
11. Ussia GP, Barbanti M, Imma S, Scartabelli M, Mula M, Cammalleri V, Aruta P, Pistritto AM, Capodanno D, Deste W, Di Pasqua MC, Tamburino C,. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 440-449.
12. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jagere PP, Serruys PW,. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Interv 2008; 1: 310-316. (Pubitemid 351804194)
13. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Andre G, Bence J, Logtens E, Kovac J,. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009; 157: 860-866.
14. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Tiene G, Gerosa G, Isabella G, Iliceto S, Napodano M,. Conduction abnormalities after transcatheter aortic valve implantation for calcific aortic valve disease. Am J Cardiol 2011; 107: 747-754.
15. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG,. Transcatheter aortic valve implantation. Review of the nature, management, and avoidance of procedural complication. J Am Coll Cardiol Interv 2009; 2: 811-820.
16. Detaint D, Lepage L, Himbert D, Brochet E, Messika-Zeitoun D, Iung B, Vahanian A,. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation. J Am Coll Cardiol Interv 2009; 2: 821-827.
17. Sherif MA, Abdel-Wahab M, Stocker B, Geist V, Richardt D, Tolg R, Richardt G,. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010; 56: 1623-1629.
18. Ussia GP, Mul M, Tamburino C,. The valve-in-valve technique: Transcatheter treatment of aortic bioprosthesis malposition. Catheter Cardiovasc Interv 2009; 73: 713-716.
19. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A,. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using the III generation corevalve revalving system. J Am Coll Cardiol Interv 2009; 2: 828-833.
20. Latib A, Michev I, Laborde JC, Montorfano M, Colombo A,. Post-implantation repositioning of the CoreValve percutaneous aortic valve. J Am Coll Cardiol Interv 2010; 3: 119-121.
21. Webb JG,. Percutaneous aortic valve replacement will become a common treatment for aortic valve disease. J Am Coll Cardiol Interv 2008; 1: 122-126. (Pubitemid 351509301)